PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Experimental Medicine, Tor Vergata University, Via Montpellier, 1, 00133, Rome, Italy. cristianoantonio93@hotmail.it.\', \'Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy. cristianoantonio93@hotmail.it.\', \'Department of Experimental Medicine, Tor Vergata University, Via Montpellier, 1, 00133, Rome, Italy.\', \'Tor Vergata University Hospital, Rome, Italy.\', \'Emerging Technologies Division, International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), Milano, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s10067-021-05580-3
?:hasPublicationType
?:journal
  • Clinical rheumatology
is ?:pmid of
?:pmid
?:pmid
  • 33464429
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.93
?:rankingScore_hIndex
  • 71
is ?:relation_isRelatedTo_publication of
?:title
  • Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all